It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but also how technology has allowed for quick and now cheap ways of mapping ...

Saylor, long known as the co-founder and head of enterprise-software firm Strategy (previously MicroStrategy), made his first ...

Fifth-generation AMD EPYC processors and RDMA cluster networking power OCI’s bare metal instances. They provide Absci with ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the pharma says can help young drugmakers while training its own models.

Recursion Pharmaceuticals, Inc. ( NASDAQ: RXRX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...

What is language, why do we use it, and how did it evolve? These are questions that language researchers are still working to answer. From a basic standpoint, a language is a shared system of symbols ...

I told her about something that the Danish philosopher Søren Kierkegaard identified back in the 19th century as “an adventure ...

According to LeDoux, the brain economizes by relying on habits and automatic responses, reserving the more energetically ...

Summary The Defender’s Log episode features John Todd from Quad9, discussing their mission to protect the internet through secure DNS. Quad9, a non-profit launched in 2017 with founding partners ...

These three companies are using artificial intelligence (AI) to transform defense, pharmaceuticals, and banking.

Drug development software maker Certara, and biotechs such as Schrodinger and Recursion Pharmaceuticals are already using AI ...